Literature DB >> 2544498

Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis.

H Emonard1, J A Grimaud.   

Abstract

In schistosomiasis mansoni, eggs trapped in portal venules of the liver induce a granulomatous inflammatory reaction and subsequently fibrosis. Upon specific schistosomicidal treatment, however, fibrosis undergoes a marked reversal. The features of this process as regards collagen metabolism were examined in mice using praziquantel as the schistosomicidal drug, which was given 68 days after infection. It was found that collagenase activity in the liver, for both latent and active forms, increases rapidly until 5 days after treatment as compared to nontreated infected mice and then diminishes gradually. The hydroxyproline content in liver and (24-hr) urine are also modified, their values decreasing progressively up to 72 days after treatment without, however, reaching values observed in normal mice. Worm death appears to be the triggering stimulus of these events.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544498     DOI: 10.1002/hep.1840100116

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.

Authors:  G Abdel-Aziz; G Lebeau; P Y Rescan; B Clément; M Rissel; Y Deugnier; J P Campion; A Guillouzo
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

Review 2.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

3.  Parasitological evaluation of Ro 15-9268, a 9-acridanone-hydrazone derivative against Schistosoma mansoni in mice, and observations on changes in serum enzyme levels.

Authors:  Sayed Rawi; Osama Abdel-Ghaffar Youssef; Aisha Metwally; Mohamed Badawy; Mansour Al-Hazmi
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

4.  Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.

Authors:  Ekhlas H Abdel-Hafeez; Azza K Ahmad; Ahlam M Abdulla; Soha Aabdel-Wahab; Fadia A Mosalem
Journal:  Parasitol Res       Date:  2012-03-08       Impact factor: 2.289

5.  Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study.

Authors:  A A Badawy; N M el-Badrawy; M M Hassan; F A Ebeid
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

6.  Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Dov L Boros
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

7.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

Authors:  S Milani; H Herbst; D Schuppan; C Grappone; G Pellegrini; M Pinzani; A Casini; A Calabró; G Ciancio; F Stefanini
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

8.  Amelioration of Murine Schistosoma mansoni Induced Liver Fibrosis by Mesenchymal Stem Cells.

Authors:  Mt Abdel Aziz; Hm Atta; Nk Roshdy; LA Rashed; D Sabry; Aa Hassouna; Gi Aboul Fotouh; Nm Hasan; Rh Younis; Jr Chowdhury
Journal:  J Stem Cells Regen Med       Date:  2012-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.